A new class of nanoparticle-based vaccines could help immunize against cancer in several years.
A new class of vaccines developed
Antigen plus immune activator – coupled to nanoparticles
The novel vaccine class consists of two components: Firstly, the antigen, which is specific to the tumor cell and is to be recognized by the immune system as an “enemy”, so to speak, and secondly, the immune activator – a “stinger” that shakes up the immune system.
As the immune activator, the researchers use the derivative of a chemical molecule that was discovered by Sunil A. David in the USA and is already being used successfully in the Indian corona vaccine Covaxin. By itself, this molecule is too active and potent and would cause violent inflammatory reactions throughout the body. Therefore, the research team attaches it to a carrier – more precisely, to polymer-based nanoparticles that have a gel-like consistency, are biodegradable and locally limit the effect of the immune activator. These nanoscale materials with diameters of less than 100 nanometers are about the size of viruses – the cells of the immune system therefore recognize them very well, eat them and in this way awaken from their dormant mode. The nanoparticles thus open up a direct pathway into the immune system. And: “By binding them to nanopolymers, we were able to throttle the immune response to the desired level,” explains Nuhn.
Vaccine specifically kills tumor cells
For the vaccine to target the tumor, you need to know: What distinguishes tumor tissue from healthy tissue – in other words, which specific antigens are found on the cancer? This may well be patient-specific. “If a tumor is diagnosed in the early stages, a race against time begins to produce the patient-specific vaccine as quickly as possible,” Nuhn explains.
To develop the new vaccine classes, the researchers first use a model antigen. They have generated various tumors that carry this model antigen – either on the surface or inside. Initial studies are promising; the T cells activated by the vaccine only kill tumor cells that carry the antigen on their surface or even inside. Healthy tissue, on the other hand, is not affected. “The polymer-based nanocarrier is a helpful toolbox to further evaluate antigen-specific vaccines and to develop further vaccine-based therapeutic concepts against cancer,” Nuhn is convinced. One thing must be said, however: Several years of further research will be needed before such vaccines can cure patients of tumors. Nor will it be possible to combat all types of cancer with a vaccine.
Original Article: Vaccinating against cancer?
The Latest on: Cancer vaccine
- Tampa’s ‘Morphogenesis’ continues skin cancer vaccine efforts with new CEOon August 5, 2022 at 8:37 am
A Tampa company developing a skin cancer vaccine has recently appointed a new CEO who plans to take the company public within the next few months.
- HPV vaccine may further curb cancer risk when treating cervical lesionson August 5, 2022 at 8:24 am
Most sexually active people will contract the human papillomavirus during their lifetimes, and about 90% will clear it from their bodies. But some women are susceptible to the cervical lesions that ...
- When Treating Cervical Lesions, Adding HPV Vaccine Could Further Curb Cancer Riskon August 5, 2022 at 7:57 am
Now, a new review finds it's possible that during surgery to remove precancerous cervical lesions, an injection of the HPV vaccine may help prevent future lesions. While the findings show great ...
- Kinnate Biopharma, led by a former vaccine CEO, hopes to reshape cancer drugson August 4, 2022 at 11:22 am
Nima Farzan was three days into his job as CEO of Kinnate Biopharma Inc. when Covid slowed the young cancer drug development company. If anyone knows about vaccines, it is Farzan. He spent nearly ...
- ‘Life-saving’ cervical cancer vaccine could be rolled out to MORE women – are you eligible?on August 4, 2022 at 9:34 am
MORE women could be offered a life saving vaccine which has been found to slash the risk of cervical cancer in those with precancerous cells. Kids aged 12 to 13 are routinely being ...
- Queen’s researchers get grant for vaccine-inspired breast cancer treatmenton August 4, 2022 at 3:09 am
Researchers plan to use mRNA, which was deployed in Covid-19 vaccines, to target a protein found in breast cancer cells.
- New Breast Cancer Treatments Inspired by mRNA COVID-19 Vaccine Innovationon August 4, 2022 at 2:00 am
Scientists at Queen’s University Belfast have received funding from Breast Cancer Now to support their quest for new treatments inspired by COVID-19 vaccine innovation. The research team will adapt le ...
- HPV vaccine after removal of precancerous cells may cut cervical cancer riskon August 3, 2022 at 2:30 pm
Study finds reduced risk of cervical cancer recurring after HPV vaccination post-surgery, though further research is needed ...
- New class of nanoparticle-based vaccines could help immunize against canceron July 27, 2022 at 5:10 am
A vaccination as tumor therapy—with a vaccine individually created from a patient's tissue sample that "attaches" the body's own immune system to cancer cells. The basis for this long-term vision has ...
- Morphogenesis gets closer to a cancer vaccineon July 27, 2022 at 3:25 am
Morphogenesis ' new CEO, James Bianco, told Axios he expects to get fast-track approval from the Food and Drug Administration for the company's therapeutic vaccine to treat certain types of skin ...
via Bing News
The Latest on: Cancer vaccine
via Google News